Walleye Trading’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1K Sell
4,153
-9,400
-69% -$103K ﹤0.01% 3761
2025
Q4
$153K Buy
13,553
+11,085
+449% +$137K ﹤0.01% 3526
2025
Q3
$37K Buy
2,468
+1,362
+123% +$19.8K ﹤0.01% 4033
2025
Q2
$15.6K Buy
+1,106
New +$19.7K ﹤0.01% 3996
2023
Q4
Sell
-15,912
Closed -$495K 5074
2023
Q3
$414K Sell
15,912
-20,557
-56% -$427K ﹤0.01% 3105
2023
Q2
$872K Buy
36,469
+15,923
+77% +$274K ﹤0.01% 2303
2023
Q1
$281K Buy
+20,546
New +$327K ﹤0.01% 3271

Other funds holding BHVN

Walleye Trading's BHVN Position: Q1 2026 in Review

Walleye Trading reduced its Biohaven (BHVN) stake by 69% in Q1 2026, selling an estimated $103K and leaving 4,153 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3761.

Walleye Trading first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $872K in Q2 2023. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Walleye Trading held 4,153 shares of Biohaven worth $35.1K as of Q1 2026.
  • Walleye Trading sold 9,400 Biohaven shares in Q1 2026, an estimated $103K.
  • Biohaven made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3761 holding.
  • Walleye Trading first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
  • Walleye Trading's Biohaven position peaked at $872K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.